Recruiting NCT06330870
Brain Metastasis Development Mechanism in BCBM Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: WGS/TME evaluation.
- Who it may be relevant to
- Registry conditions: Breast Cancer, Brain Metastasis. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)
Overview
This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis
Interventions
- Procedure WGS/TME evaluation
WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis curative surgery
Primary outcome measures
- Intracranial disease free survival [Time frame: Months]
Eligibility criteria
Inclusion criteria
- Breast cancer
- Brain metastasis curative surgery patient
Exclusion criteria
- Gamma Knife surgery patient
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Screening
Study locations
South Korea · 1 center
- Ji-Yeon Kim — Seoul
Identifiers
NCT: NCT06330870 · BCBM_Breast